Henan Lingrui Pharmaceutical Co Ltd (600285) - Total Assets
Based on the latest financial reports, Henan Lingrui Pharmaceutical Co Ltd (600285) holds total assets worth CN¥5.97 Billion CNY (≈ $872.97 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Henan Lingrui Pharmaceutical Co Ltd (600285) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Henan Lingrui Pharmaceutical Co Ltd - Total Assets Trend (1997–2025)
This chart illustrates how Henan Lingrui Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See Henan Lingrui Pharmaceutical Co Ltd book value and equity for net asset value and shareholders' equity analysis.
Henan Lingrui Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Henan Lingrui Pharmaceutical Co Ltd's total assets of CN¥5.97 Billion consist of 40.5% current assets and 59.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 6.8% |
| Accounts Receivable | CN¥430.40 Million | 7.6% |
| Inventory | CN¥436.64 Million | 7.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥343.17 Million | 6.1% |
| Goodwill | CN¥482.02 Million | 8.6% |
Asset Composition Trend (1997–2025)
This chart illustrates how Henan Lingrui Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Henan Lingrui Pharmaceutical Co Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Henan Lingrui Pharmaceutical Co Ltd's current assets represent 40.5% of total assets in 2025, a decrease from 60.8% in 1997.
- Cash Position: Cash and equivalents constituted 6.8% of total assets in 2025, down from 12.4% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 7.0% in 1997.
- Asset Diversification: The largest asset category is goodwill at 8.6% of total assets.
Henan Lingrui Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Henan Lingrui Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
JW Pharmaceutical Corp
KO:001067
|
Korea | ₩611.56 Billion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275
|
China | CN¥4.30 Billion |
|
Fuan Pharmaceutical Group Co
SHE:300194
|
China | CN¥5.97 Billion |
|
DRI Healthcare Trust
TO:DHT-U
|
Canada | $967.26 Million |
|
Hainan Shuangcheng Pharmaceut
SHE:002693
|
China | CN¥816.14 Million |
Henan Lingrui Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.17 | 1.01 | 1.46 |
| Quick Ratio | 0.99 | 0.82 | 1.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥375.24 Million | CN¥18.30 Million | CN¥634.71 Million |
Henan Lingrui Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Henan Lingrui Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.21 |
| Latest Market Cap to Assets Ratio | 0.33 |
| Asset Growth Rate (YoY) | 12.3% |
| Total Assets | CN¥5.64 Billion |
| Market Capitalization | $1.84 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Henan Lingrui Pharmaceutical Co Ltd's assets below their book value (0.33x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Henan Lingrui Pharmaceutical Co Ltd's assets grew by 12.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Henan Lingrui Pharmaceutical Co Ltd (1997–2025)
The table below shows the annual total assets of Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.64 Billion ≈ $824.65 Million |
+12.33% |
| 2024-12-31 | CN¥5.02 Billion ≈ $734.12 Million |
+5.13% |
| 2023-12-31 | CN¥4.77 Billion ≈ $698.28 Million |
+9.84% |
| 2022-12-31 | CN¥4.34 Billion ≈ $635.72 Million |
+14.53% |
| 2021-12-31 | CN¥3.79 Billion ≈ $555.05 Million |
+9.70% |
| 2020-12-31 | CN¥3.46 Billion ≈ $505.98 Million |
+4.28% |
| 2019-12-31 | CN¥3.32 Billion ≈ $485.20 Million |
+6.62% |
| 2018-12-31 | CN¥3.11 Billion ≈ $455.09 Million |
-5.97% |
| 2017-12-31 | CN¥3.31 Billion ≈ $484.00 Million |
+10.94% |
| 2016-12-31 | CN¥2.98 Billion ≈ $436.29 Million |
+10.07% |
| 2015-12-31 | CN¥2.71 Billion ≈ $396.36 Million |
+9.46% |
| 2014-12-31 | CN¥2.47 Billion ≈ $362.09 Million |
+50.14% |
| 2013-12-31 | CN¥1.65 Billion ≈ $241.17 Million |
+27.33% |
| 2012-12-31 | CN¥1.29 Billion ≈ $189.40 Million |
+7.14% |
| 2011-12-31 | CN¥1.21 Billion ≈ $176.77 Million |
+0.76% |
| 2010-12-31 | CN¥1.20 Billion ≈ $175.44 Million |
+17.06% |
| 2009-12-31 | CN¥1.02 Billion ≈ $149.87 Million |
+5.78% |
| 2008-12-31 | CN¥968.27 Million ≈ $141.69 Million |
+2.73% |
| 2007-12-31 | CN¥942.55 Million ≈ $137.92 Million |
+7.27% |
| 2006-12-31 | CN¥878.69 Million ≈ $128.58 Million |
+0.74% |
| 2005-12-31 | CN¥872.24 Million ≈ $127.64 Million |
+5.24% |
| 2004-12-31 | CN¥828.81 Million ≈ $121.28 Million |
+11.80% |
| 2003-12-31 | CN¥741.34 Million ≈ $108.48 Million |
+6.25% |
| 2002-12-31 | CN¥697.75 Million ≈ $102.10 Million |
+24.51% |
| 2001-12-31 | CN¥560.38 Million ≈ $82.00 Million |
+8.85% |
| 2000-12-31 | CN¥514.79 Million ≈ $75.33 Million |
+194.13% |
| 1999-12-31 | CN¥175.02 Million ≈ $25.61 Million |
+39.31% |
| 1998-12-31 | CN¥125.63 Million ≈ $18.38 Million |
+40.08% |
| 1997-12-31 | CN¥89.69 Million ≈ $13.12 Million |
-- |
About Henan Lingrui Pharmaceutical Co Ltd
Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orth… Read more